Cervical Ripening Balloon in Induction of Labour at Term
CRBII
1 other identifier
interventional
417
1 country
1
Brief Summary
About 1 in 6 deliveries in KKH are induced with prostaglandins. Inpatient induction can be a lengthy process especially when cervical priming is required. Although mechanical method of induction of labour (IOL) is established, its use in Singapore is uncommon. Systematic reviews comparing mechanical method against pharmacological and surgical IOL showed that mechanical method has similar efficacy with lower risk profile. As IOL is a common obstetric procedure, a revisit on the techniques is warranted. A multi-centre randomised controlled trial concluded that both cervical ripening balloon and prostaglandin are effective and complementary methods for IOL in uncomplicated singleton pregnancies, but did not examined the effects of pain. The investigators propose to evaluate the adverse events in the 12 hours after CRB or 1st prostaglandin insertion, its efficiency in term singleton IOL in Singapore context and test the acceptability of women in Singapore in using the CRB as an alternative method of induction of labour while using a non-incremental balloon filling regime. Currently, there is no efficient method of induction that can be used safely in an outpatient setting. Through this study, the investigators hope to show that there are no major adverse events in the 12h after patients are induced with CRB, this potentially supports outpatient IOL with CRB which can reduce hospitalisation and medical costs. A non-incremental balloon filling regime will decrease time delays and may increase patient satisfaction during its use in induction of labour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 pregnancy
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 9, 2015
CompletedFirst Posted
Study publicly available on registry
December 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2017
CompletedAugust 16, 2018
August 1, 2018
2.1 years
November 9, 2015
August 14, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse events in the first 12 hours after Cook's Cervical Ripening Balloon insertion for induction of labour, in comparison to 1st prostin insertion
Up to 24 hours after induction of labour
Secondary Outcomes (3)
Efficacy of Cook's Cervical Ripening Balloonas a devide for induction of labour, in comparison to prostin, in achieving vaginal deliveries
Up to 96 hours after delivery
Patient satisfaction of the Cook's Cervical Ripening Balloon as a devide for induction of labour, in comparison to prostin, by using a 10-point scale
From induction of labour to up to 4 days after delivery
Patients' experience of the Cook's Cervical Ripening Balloon as a devide for induction of labour, in comparison to prostin, by using a 10-point pain assessment scale
From induction of labour to up to 4 days after delivery
Study Arms (2)
Cervical Ripening Balloon
EXPERIMENTALCook® Cervical Ripening Balloon with Stylet Order number G19891 Reference Part Number J-CRBS-184000 Catheter (Fr) 18.0 Length (cm) 40 Balloon Volume (mL) 80
Prostin
ACTIVE COMPARATORProstin E2 vaginal tablets contain the active ingredient dinoprostone, which is a naturally occuring female hormone also known as prostaglandin E2. Prostaglandins are involved in naturally starting labour. Dose of Prostin is 3 mg vaginally.
Interventions
Cook® Cervical Ripening Balloon with Stylet Order number G19891 Reference Part Number J-CRBS-184000 Catheter (Fr) 18.0 Length (cm) 40 Balloon Volume (mL) 80
Prostin E2 vaginal tablets contain the active ingredient dinoprostone, which is a naturally occuring female hormone also known as prostaglandin E2. Prostaglandins are involved in naturally starting labour. Dose of Prostin is 3 mg vaginally.
Eligibility Criteria
You may qualify if:
- Pregnant women aged 21 - 40 years old
- Singleton pregnancy with no major fetal anomaly
- Planned induction of labour at 37+0 weeks to 41+6 weeks gestation
- Vaginal delivery is appropriate
- Patient able to give informed consent to participate in the trial
You may not qualify if:
- Spontaneous labour at start of planned induction
- Bishop score \<6 and cervical dilatation \>=3 cm at start of induction
- Confirmed rupture of membrane
- Abnormal CTG at start of induction
- Caesarean section delivery is indicated
- Scarred uterus such as previous caesarean section
- Malpresentation in labour
- Latex allergy, severe asthma and glaucoma
- Patient withdraw consent to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KK Women's and Children's Hospitallead
- University of Malayacollaborator
Study Sites (1)
KK Women's and Children's Hospital
Singapore, Singapore
Related Publications (2)
de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.
PMID: 36996264DERIVEDGrace Ng YH, Aminuddin AA, Tan TL, Kuppusamy R, Tagore S, Yeo GSH. Multicentre randomised controlled trial comparing the safety in the first 12 h, efficacy and maternal satisfaction of a double balloon catheter and prostaglandin pessary for induction of labour. Arch Gynecol Obstet. 2022 Jan;305(1):11-18. doi: 10.1007/s00404-021-06090-y. Epub 2021 May 11.
PMID: 33973051DERIVED
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Shephali Tagore, MRCOG
KK Women's and Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant
Study Record Dates
First Submitted
November 9, 2015
First Posted
December 2, 2015
Study Start
November 1, 2015
Primary Completion
December 7, 2017
Study Completion
December 7, 2017
Last Updated
August 16, 2018
Record last verified: 2018-08